A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

NCT05334823 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Relapsed Pediatric ALL
Refractory Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: pCAR-19B cells

Sponsor

Chongqing Precision Biotech Co., Ltd